戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s found to correlate with acute rejection by transbronchial biopsy.
2  treatable infection was diagnosed only with transbronchial biopsy.
3 lop once disease recurrence had been seen on transbronchial biopsy.
4 esence or absence of acute lung rejection on transbronchial biopsy.
5 Ab was determined at the same frequency with transbronchial biopsies.
6 of humoral immunity is a frequent finding on transbronchial biopsies.
7 oscopy with bronchoalveolar lavage (BAL) and transbronchial biopsies.
8  by HRCT, whereas 35.2% had abnormalities on transbronchial biopsies.
9  evaluation and fiberoptic bronchoscopy with transbronchial biopsies and bronchoalveolar lavage exclu
10 c diagnoses were made with 29 (34.9%) of the transbronchial biopsies, and patient management was chan
11 aluated by clinical history and examination, transbronchial biopsy, and high-resolution lung computed
12                                              Transbronchial biopsies are insufficiently sensitive to
13         CCSP-positive cells were assessed in transbronchial biopsies at 1 and 3 months.
14                       Airway inflammation in transbronchial biopsies (B score) correlated with NT in
15                   Seventy-seven patients had transbronchial biopsies demonstrating BALT.
16   We evaluated complications associated with transbronchial biopsy, diagnostic yield of the procedure
17                                              Transbronchial biopsies from 29 bronchoscopic procedures
18             Bronchoalveolar lavage (BAL) and transbronchial biopsies from 351 human immunodeficiency
19                                              Transbronchial biopsies from all lung transplant recipie
20                     Longitudinal analysis of transbronchial biopsies from human lung transplant recip
21 way endobronchial and distal alveolar tissue transbronchial biopsy in a random order at 4:00 P.M. and
22 way endobronchial and distal alveolar tissue transbronchial biopsy in a random order at 4:00 P.M. and
23 tologic associations with BALT identified on transbronchial biopsy in human lung allograft recipients
24                             CCSP+ve cells in transbronchial biopsies increased at 3 months only in LT
25                                              Transbronchial biopsy is performed, and pathology yields
26 the possibility that the presence of BALT on transbronchial biopsy may be part of the evolution of im
27                                              Transbronchial biopsies (n=104) from 29 human lung trans
28                                              Transbronchial biopsies of patients receiving single lun
29 ance and 146 patients who underwent ENB with transbronchial biopsy of a lung lesion between 2013 and
30  bronchoscopist improved the success rate of transbronchial biopsy of subcarinal and aortopulmonary l
31            Retrospective chart review of all transbronchial biopsies performed within the first 2 yea
32 esently, histologic examination of tissue by transbronchial biopsy remains as the definitive diagnost
33                                              Transbronchial biopsy revealed adiaspores of the fungus
34 se samples (from 25 patients), corresponding transbronchial biopsy samples were available for CMV imm
35 ular antigen-staining and rare bacilli while transbronchial biopsies showed granular antigen-staining
36           Pathologic correlation between the transbronchial biopsy specimens and lung tissue obtained
37 sults were obtained in the endobronchial and transbronchial biopsy specimens, which consistently show
38 ults were compared with lavage and endo- and transbronchial biopsy studies in normal controls and pat
39       This retrospective study comprised all transbronchial biopsies (TBB) obtained during the first
40 onventional methods [BAL microbiological and transbronchial biopsy (TBB) analyses].
41 ografts using endobronchial biopsy (EBB) and transbronchial biopsy (TBB) from 22 lung transplant pati
42  study of consecutive patients who underwent transbronchial biopsy (TBBx) for evaluation of periphera
43                                              Transbronchial biopsy to sample lymph nodes and tumors t
44                         For messenger RNA in transbronchial biopsies, trends (p > 0.05 and <or= 0.10)
45                                              Transbronchial biopsy was performed in 36 patients, of w
46                                              Transbronchial biopsies were also obtained when possible
47                            Endobronchial and transbronchial biopsies were performed in selected patie
48                                          All transbronchial biopsies were regraded 0 to 4 for acute p

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。